Foy, Shaun Patrick
Status:
Ceased
Notified: 10/02/2017
Ceased: 19/04/2021
Date of Birth: 02/1970
Nature of ControlOwnership of shares – More than 25% but not more than 50%
GB
Glaxosmithkline Finance Plc
Status:
Ceased
Notified: 29/07/2020
Ceased: 17/09/2020
Companies House Number: 00242686
Nature of ControlOwnership of shares – More than 25% but not more than 50%Ownership of voting rights - More than 25% but not more than 50%
Novak, Rodger
Status:
Ceased
Notified: 28/04/2020
Ceased: 19/04/2021
Date of Birth: 06/1967
Nature of ControlOwnership of shares – More than 25% but not more than 50%
Foy, Matthew
Cambridge, United Kingdom
Status:
Active
Notified: 05/09/2017
Date of Birth: 04/1980
Occupation: Biotech Venture Capital
Role: Director
Country of Residence: England
Nationality: British
Foy, Shaun Patrick
Cambridge, United Kingdom
Status:
Active
Notified: 10/02/2017
Date of Birth: 02/1970
Occupation: Entrepreneur
Role: Director
Country of Residence: United Kingdom
Nationality: Canadian
George, Simeon John
Cambridge, United Kingdom
Status:
Active
Notified: 05/09/2017
Date of Birth: 03/1977
Occupation: Venture Capital
Role: Director
Country of Residence: United States
Nationality: British,American
Novak, Rodger
Cambridge, United Kingdom
Status:
Active
Notified: 27/04/2020
Date of Birth: 06/1967
Occupation: Company Director
Role: Director
Country of Residence: Switzerland
Nationality: German
Stevens, Josephine Angela
Cambridge, United Kingdom
Status:
Active
Notified: 19/07/2022
Role: Secretary
Goldsmith, Bruce
Cambridge, United Kingdom
Status:
Ceased
Notified: 27/04/2023
Ceased: 14/12/2023
Date of Birth: 12/1965
Occupation: Chief Executive Officer
Role: Director
Country of Residence: United States
Nationality: American